Neurology

Neuroinflammation in Depression: Biomarker or Target?

by Similoluwa Oluwalana - 017

Neuroinflammation in Depression: Biomarker or Target?  Abstract Major depressive disorder (MDD) remains a leading global cause of disability, yet its underlying pathophysiology is incompletely understood. Increasing evidence implicates immune and inflammatory processes in the onset, progression, and treatment response of depression. This review synthesizes current

Early Intervention Autism: New Research Shows 87% Success Rate at 18 Months

by Nancy Ogbonna - 0110

Early Intervention Autism: New Research Shows 87% Success Rate at 18 Months Check back later for a possible video summary. Videos are created for most articles.   Introduction Early intervention strategies for Autism Spectrum Disorder (ASD) have gained increasing importance as global prevalence

The Hidden Burden of Subclinical Hypothyroidism: When to Treat and When to Watch

by Nancy Ogbonna - 0122

The Hidden Burden of Subclinical Hypothyroidism: When to Treat and When to Watch Check back later for a possible video summary. Videos are created for most articles.   Abstract Background:Subclinical hypothyroidism (SCH) is defined by elevated serum thyroid-stimulating hormone (TSH) levels alongside normal free thyroxine

How Deep Brain Stimulation Repairs Neural Pathways to End the Addiction Cycle

by Similoluwa Oluwalana - 0157

How Deep Brain Stimulation Repairs Neural Pathways to End the Addiction Cycle   Please like and subscribe if you enjoyed this video :-)     Introduction Drug addiction causes 11.8 million deaths each year, surpassing all cancer deaths combined. It has prompted experts to research other treatment modalities

Vitamin D Levels Linked to Neuropsychiatric Outcomes

by Nancy Ogbonna - 0215

Vitamin D Levels Linked to Neuropsychiatric Outcomes Please like and subscribe if you enjoyed this video :-)    Abstract This paper provides a comprehensive review of current scientific evidence on the relationship between vitamin D levels and neuropsychiatric outcomes. With growing interest

Smart Devices Detect Early Cognitive Decline

by Nancy Ogbonna - 0130

Smart Devices Detect Early Cognitive Decline Please like and subscribe if you enjoyed this video :-)    Abstract This paper explores the growing potential of smart technology in the early detection and monitoring of cognitive decline. As the prevalence of dementia and Alzheimer’s disease continues

New Treatments for Migraines: What Actually Works in 2025?

by Nancy Ogbonna - 01169

New Treatments for Migraines: What Actually Works in 2025? Introduction Migraine affects approximately 10% of the global population, including 25% of adult women and 9% of children. It ranks as the third leading cause of years lived with disability, according to the 2019 Global Burden of Disease

Remyelination in MS: Scientists Uncover Promising Treatment Pathway

by Nancy Ogbonna - 0588

Remyelination in MS: Scientists Uncover Promising Treatment Pathway Introduction Multiple sclerosis (MS) research has entered a transformative phase with the emergence of two promising therapies aimed at restoring myelin, the protective sheath around nerve fibers that is progressively damaged in MS. Affecting an estimated 2.5 million

Stroke Technology in 2025: New Treatments Giving Patients a Second Chance

by Nancy Ogbonna - 0279

Stroke Technology in 2025: New Treatments Giving Patients a Second Chance Please like and subscribe if you enjoyed this video :-)   Introduction Stroke remains a major public health concern in the United States, impacting approximately 795,000 individuals each year. However,

Neuroinflammation in Depression: Biomarker or Target?